Compound information
- Natural Products
- ZC2851603
- Molecular Formula
- C18H19Cl2N3O
- Molecular Weight
- 363.090517588 g/mol
- Structure
-
- IUPAC Name
- 4-(5-chloro-2-methyl-phenyl)-N-(4-chlorophenyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C18H19Cl2N3O/c1-13-2-3-15(20)12-17(13)22-8-10-23(11-9-22)18(24)21-16-6-4-14(19)5-7-16/h2-7,12H,8-11H2,1H3,(H,21,24)
- InChI Key
- UQSJMUSSYWOJBT-UHFFFAOYSA-N
- SMILES
- Cc1ccc(Cl)cc1N1CCN(C(=O)Nc2ccc(Cl)cc2)CC1
- Source
- ZINC000002562096
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 35.58 Å2 | LogP | 4.881 |
LogS | -5.975 | LogD | 4.242 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.995 | Pgp substrate | 0.932 |
HIA | 0.965 | F20 % | 0.992 |
F30 % | 0.979 | Caco-2 | -4.867 |
MDCK | -4.781 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.006 | PPB | 98.787 |
VD | 1.048 | Fu | 1.969 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.45 | CYP1A2 substrate | 0.832 |
CYP2A6 substrate | 0.725 | CYP2B6 substrate | 0.698 |
CYP2C19 inhibitor | 0.854 | CYP2C19 substrate | 0.905 |
CYP2C8 substrate | 0.93 | CYP2C9 inhibitor | 0.589 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.62 |
CYP2D6 substrate | 0.987 | CYP2E1 substrate | 0.98 |
CYP3A4 inhibitor | 0.368 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.375 | CL | 3.565 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.981 | Hepatotoxicity | 0.996 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.215 |
FDAMDD | 0.418 | Skin Sensitization | 0.882 |
Carcinogenicity | 0.92 | Eye Corrosion | 0.003 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.181 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.134 | IGC50 | 3.973 |
LC50FM | 1.125 | LC50DM | -1.814 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.432 | NR-AR-LBD | 0.216 |
NR-AhR | 0.816 | NR-Aromatase | 0.294 |
NR-ER | 0.547 | NR-ER-LBD | 0.397 |
NR-PPAR-gamma | 0.359 | SR-ARE | 0.846 |
SR-ATAD5 | 0.601 | SR-HSE | 0.161 |
SR-MMP | 0.635 | SR-p53 | 0.699 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.